Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Gim Hwa Tan"'
Autor:
Gim Hwa Tan, Sheng Chun Chang, Richie Soong, Mohd Feroz Mohd Omar, Daniel Q. Huang, Min Ji Han, Benny Tang, Bhaskar Bhattacharya, Sarah Hong Hui Low, Yock Young Dan, Sanamerjit Singh, Joey Sze Yun Lim
Publikováno v:
Oncotarget
The native hepatocellular cancer (HCC) microenvironment is characterized by more hypoxic, hypoglycemic, and acidic conditions than those used in standard cell culture. This study aimed to investigate whether HCC cells cultured in more native conditio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48a8e0ff5bb0c15ffa4ea22fe339e6e1
https://pubmed.ncbi.nlm.nih.gov/33868588
https://pubmed.ncbi.nlm.nih.gov/33868588
Autor:
Bhaskar Bhattacharya, Mounia Beloueche-Babari, Richie Soong, Gim Hwa Tan, Mohd Feroz Mohd Omar, Min Ji Han, Ross A. Soo, King Xin Koh, Sarah Hong Hui Low, Barry Iacopetta
Publikováno v:
Oncotarget
Acquired resistance (AQR) to drug treatment occurs frequently in cancer patients and remains an impediment to successful therapy. The aim of this study was to gain insight into how AQR arises following the application of PI3K/mTOR inhibitors. H1975 l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44e6a31235a38e6be70a9237b0e15bfe
https://doi.org/10.18632/oncotarget.22655
https://doi.org/10.18632/oncotarget.22655
Autor:
Sarah Hong Hui Low, Benny Tang, Gim Hwa Tan, Richie Soong, Mohd Feroz Mohd Omar, Bhaskar Bhattacharya, Sheng Chun Chang
Publikováno v:
Cancer Research. 77:165-165
Background: Hepatocellular carcinoma (HCC) is characterized by hypoxia, hypoglycemia and lactic acidosis within the microenvironment due a highly glycolytic phenotype. However, routine culture conditions of HCC cells employ supra-physiological glucos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7db43330713576b7551f258a22fee9bd
https://doi.org/10.1158/1538-7445.am2017-165
https://doi.org/10.1158/1538-7445.am2017-165
Autor:
Gim Hwa Tan, Richie Soong, Sanamerjit S. Mann, Barry E. McGuinness, Alan Wise, Sarah Hh Low, Phillip M. Cowley, Sarah C. Trewick, Min Ji Han, Bhaskar Bhattacharya
Publikováno v:
Cancer Research. 76:1283-1283
Hepatocellular carcinoma (HCC) is an endemic disease globally, with a 5-year survival rate of 15%. Current treatment of late-stage HCC involves the use of chemotherapy and sorafenib, a multi-kinase inhibitor. Metabolic studies have indicated HCC has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f51cf86259f994be268b532b26066868
https://doi.org/10.1158/1538-7445.am2016-1283
https://doi.org/10.1158/1538-7445.am2016-1283